Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
49,372,145
-
Share change
-
-1,350,742
-
Total reported value
-
$8,877,448,808
-
Put/Call ratio
-
144%
-
Price per share
-
$179.81
-
Number of holders
-
241
-
Value change
-
+$726,181,614
-
Number of buys
-
152
-
Number of sells
-
143
Institutional Holders of KITE PHARMA INC - COM (KITE) as of Q3 2017
As of 30 Sep 2017,
KITE PHARMA INC - COM (KITE) was held by
241 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,372,145 shares.
The largest 10 holders included
COWEN INC., BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, Wildcat Capital Management, LLC, FMR LLC, JPMORGAN CHASE & CO, STATE STREET CORP, Tyrus Capital S.A.M., and Capital World Investors.
This page lists
241
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.